Related Experiment Video
Updated: Jan 13, 2026

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
Published on: May 23, 2025
Targeted CRISPR knockout screening identifies known and novel chemogenomic interactions between DNA damaging agents
Collin D Heer1, James L Elia2, Vijay Menon1
1Department of Therapeutic Radiology, Yale University, New Haven, CT 06510, United States.
Abstract:
Genetic instability is a hallmark of cancer, often arising from mutations to DNA damage repair and response (DDR) genes. Classical genetic, biochemical, and structural approaches elucidated the foundational mechanisms of DDR pathways and provided a scientific understanding of their involvement in repair of lesions induced by broad classes of DNA-damaging agents (DDAs). However, given the chemical diversity of DDAs and resultant DNA lesions, along with the multitude of interconnected DDR factors, the chemogenomic landscape of DDA-DDR interactions remains incompletely mapped. To this end, we developed a DDR-targeted, CRISPR knockout screening approach and assessed relationships amongst 353 DNA repair genes and 15 DDAs in LN229 glioma cells. Within this dataset of 5295 DDR-related chemogenomic interactions, we identified many established interactions and discovered novel ones. For example, we observed a specific role of transcription-coupled nucleotide excision repair in the repair of adducts generated by monofunctional alkylating agents, a role for the Fanconi anemia pathway in addressing methyl lesions, overt differences in DSB repair following treatment with topoisomerase I versus II poisons, and repair dependencies associated with the imidazotetrazines temozolomide, mitozolomide, and KL-50. Future directions will continue to investigate the mechanisms of novel chemogenomic interactions that we have uncovered as well as work to identify chemogenomic interactions amenable to clinical translation.
Insights
This study maps the complex interactions between DNA damage repair (DDR) genes and DNA-damaging agents (DDAs) using CRISPR screening. Researchers uncovered novel DDR-DDA relationships, advancing cancer therapy insights.
Area of Science:
- Genetics
- Cancer Biology
- Molecular Biology
Background:
- Genetic instability, driven by DNA damage repair (DDR) gene mutations, is central to cancer development.
- While DDR pathways are understood, the full chemogenomic landscape of DNA-damaging agent (DDA) interactions remains largely unmapped.
- The chemical diversity of DDAs and the complexity of DDR networks necessitate comprehensive interaction mapping.
Purpose of the Study:
- To systematically map the chemogenomic interactions between DDR genes and DDAs.
- To identify novel DDR-DDA relationships using a high-throughput screening approach.
- To understand the specific roles of DDR pathways in response to various DNA-damaging agents.
Main Methods:
- Developed and employed a DDR-targeted CRISPR knockout screening strategy.
- Assessed interactions between 353 DNA repair genes and 15 distinct DDAs in LN229 glioma cells.
- Analyzed a dataset comprising 5295 DDR-related chemogenomic interactions.
Main Results:
- Identified numerous established and novel DDR-DDA interactions.
- Revealed a specific role for transcription-coupled nucleotide excision repair in repairing alkylating agent adducts.
- Demonstrated pathway-specific repair dependencies, including the Fanconi anemia pathway for methyl lesions and distinct double-strand break repair following topoisomerase poison treatment.
- Uncovered repair dependencies for imidazotetrazine drugs like temozolomide.
Conclusions:
- The study provides a comprehensive map of DDR-DDA chemogenomic interactions, revealing novel functional relationships.
- Findings highlight specific DDR pathway involvements in repairing diverse DNA lesions induced by various agents.
- Uncovered interactions offer potential targets for developing novel cancer therapies and improving existing treatments.
Related Concept Videos
Homologous Recombination
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
CRISPR/Cas9 Genome Editing

